| Product Code: ETC8695429 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Oman Non-Small Cell Lung Cancer Diagnostics Market Overview |
3.1 Oman Country Macro Economic Indicators |
3.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Oman Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle |
3.4 Oman Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces |
3.5 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.8 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Oman Non-Small Cell Lung Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Oman |
4.2.2 Advancements in diagnostic technologies for early detection |
4.2.3 Rising awareness about the importance of early diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Limited access to advanced diagnostic facilities in certain regions of Oman |
4.3.2 High cost associated with diagnostic tests and treatments |
4.3.3 Lack of trained healthcare professionals specialized in non-small cell lung cancer diagnostics |
5 Oman Non-Small Cell Lung Cancer Diagnostics Market Trends |
6 Oman Non-Small Cell Lung Cancer Diagnostics Market, By Types |
6.1 Oman Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F |
6.1.4 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F |
6.1.5 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F |
6.1.6 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Oman Non-Small Cell Lung Cancer Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F |
6.2.3 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F |
6.3 Oman Non-Small Cell Lung Cancer Diagnostics Market, By Test |
6.3.1 Overview and Analysis |
6.3.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.3.3 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F |
6.3.4 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.5 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F |
6.3.6 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F |
6.3.7 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.4 Oman Non-Small Cell Lung Cancer Diagnostics Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.4 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F |
6.4.5 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Oman Non-Small Cell Lung Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Oman Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries |
7.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries |
8 Oman Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators |
8.1 Average time taken for diagnosis from initial symptoms presentation |
8.2 Percentage of non-small cell lung cancer cases diagnosed at an early stage |
8.3 Adoption rate of new diagnostic technologies in non-small cell lung cancer diagnostics |
9 Oman Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment |
9.1 Oman Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Oman Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F |
9.4 Oman Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Oman Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape |
10.1 Oman Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Oman Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here